BIOFERMIN PHARMACEUTICAL CO.,LTD.
ビオフェルミン製薬株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4517
FY2020 · 2021-03-31
| Gross margin | 58.4% |
| Operating margin | 19.0% |
| Net margin | 14.3% |
| Return on equity | — |
| Return on assets | 4.6% |
| Revenue growth (YoY) | -9.3% |
| EPS (basic) | ¥129.45 |
| EPS growth (YoY) | -30.9% |
| Current ratio | 10.34x |
| Equity ratio | 88.3% |
| Book value / share | ¥2,541.33 |
| Free cash flow | -2,621 M |